Validation of a Framework for Evaluating the Potential Effects and Risks of Trace Organic Compounds (TOrCs) to Aquatic Life

Similar documents
Validation of a Framework for Evaluating the Potential Effects and Risks of Trace Organic Compounds (TOrCs) to Aquatic Life

Project Objectives. Model Fate and Transport of Microcontaminants in AWT Effluent. Evaluate Advanced Wastewater Treatment through Pilot Testing

Effects of Endocrine Disrupting Compounds on Fish What do we know and what don t we know?

THE IMPACT ENDOCRINE DISRUPTING CHEMICALS (EDC S) DISCHARGED FROM WASTE WATER TREATMENT PLANTS HAVE ON RIVER SYSTEMS AND AQUATIC LIFE.

Understanding sources, management, and impact of Endocrine Disrupting Compounds (EDCs) in the Potomac

Understanding sources, management, and impact of Endocrine Disrupting Compounds (EDCs) in the Potomac

Wastewater Treatment Plant Endocrine Disrupting Compound Monitoring Study. Preliminary progress report to the Legislature

Pharmaceuticals and Endocrine Disrupting Compounds in Cape Cod Surface Waters and Groundwater

Status of PPCP Research in Biosolids and Michigan Waters. Sheridan Kidd Haack, PhD US Geological Survey Lansing, MI

Ocean Outfall Rule Compliance. Piloting Alternative Technologies for Recharge of the Floridan Aquifer. June 20, PD-Sw202w

Diagnostic Tools to Evaluate Impacts of Trace Organic Compounds on Aquatic Populations and Communities. Jerry Diamond, Ph.D. Tetra Tech, Inc.

Orange County Chapter

Contaminants of Emerging Concern in Cape Cod Groundwater and Drinking Water

Setting the Course for Improved Water Quality Tackling a Biological Impairment: The Groundhouse River TMDL Study Case Example

Ocean Outfall Rule Compliance. Piloting Alternative Technologies for Recharge of the Floridan Aquifer. July 8, PD-Sw202w

Wastewater Treatment Plant Endocrine Disrupting Chemical Monitoring Study

Microconstituents of Concern in Wastewater Treatment

Luke R Iwanowicz USGS, Leetown Science Center, National Fish Health Research Laboratory, Kearneysville, WV

The Future of Treatment: Advanced Technologies for Emerging Contaminants

Presence of Pharmaceuticals and Pesticides in Detroit River Water and the Effect of Ozone on Removal

ASSESSING THE IMPACTS ON AQUATIC ORGANISMS EXPOSED TO EMERGING CONTAMINANTS IN WASTEWATER DISCHARGES

The Effect of Stormwater on Wastewater Treatability: A study of targeted Emerging Contaminants at a Wastewater Treatment Plant

Emerging micropollutant removal from wastewater using membrane technologies

Evaluation of Quality Standards (EQS) and Predicted No Effect Concentrations (PNEC)

Good morning, Chairman Yaw, Chairman Yudichak and members of the Senate

A Multi-tiered Approach for Biological Assessment of Urban Streams U.S. Department of the Interior U.S. Geological Survey

Automated Online SPE for LC/MS/MS Analysis of Trace Organic Contaminants in Water Using the Agilent 1290 Infinity Flexible Cube Module

Ozone Oxidation of Endocrine Disruptors and Pharmaceuticals in Surface Water and Wastewater

Research Opportunities and Upcoming Issues

Delaware River Basin. Sampling Locations

Status report on pharmaceuticals in the Baltic Sea. Dmitry Frank-Kamenetsky HELCOM

Emerging Contaminants

A Comprehensive Bench- and Pilot-Scale Investigation of Trace Organic Compound Rejection by Forward Osmosis

Xylem s fully integrated, ozone-enhanced biologically active filtration system for sensitive waters

Managing active pharmaceutical ingredients (API) in manufacturing effluent Kelly Kappler Johnson & Johnson April 26, 2017

Topics. Advanced Wastewater Treatment Processes. US Federal Regulation. Status of Nutrient Regulation in Texas. Texas 2 nd Effluent Limitations

How Do Wastewater Facilities Address Contaminants in Water? Jim Pletl, Ph.D.

Dr Dimitra VOUTSA, Assistant Professor

Application Note. Abstract. Authors. Environmental

Direct Potable Reuse

Statewide Endocrine Disrupting Compound Monitoring Study

Department of Civil Engineering, University of Minnesota, Minneapolis, Minnesota

Health Effects of Pharmaceuticals in the Water Supply: A Knowledge Synthesis

and Drinking Water Issues

Water, Wastewater and Recycled Water Community: Constituents of Emerging Concern Study Experience. September 30, 2009

Product Chemicals in Minnesota Waters

Chemical Mixtures. Executive Summary from a SETAC Pellston Workshop March 2015 Valencia, Spain

Status of Pharmaceuticals and Personal Care Products (PPCPs) in River Water and Wastewater and Evaluation of their Effects on Aquatic Organisms

Pharmaceuticals and Personal Care Products in Water OW Perspective

Evaluation of Strategies to Manage Trace Organic Compounds in Water (WRF #4494) Wednesday, June 24, :00-3:00 pm ET

Constituents of Emerging Concern: Another Environmental Threat or a Policy Opportunity?

Captains of the MWRD PC-1 boat MWRD R&D Laboratory staff Countless others at MWRD and GLNPO who helped to collect fish and effluent samples

Stormwater Runoff & Pesticides What Monitoring Done Elsewhere May Suggest for South Portland

Environmental Fate and Effects Division: Who We Are and What We Do!

CONTAMINANTS OF EMERGING CONCERN

PPCP s in Private Wells An Emerging Concern? Jack Bennett State of Connecticut Department of Public Health

Risk modelling of pharmaceuticals in the environment

Risk Assessment 10/18/2012. Methodology Overview. Incineration. Disposal in biosolids lagoons (i.e., surface disposal units)

Baltic Marine Environment Protection Commission

Okanagan Estrogens Project

Occurrence and Elimination of Organic Micro Pollutants in Wastewater Treatment Plants

Pharmaceuticals in the Environment Exposure, Effects, and Risks to Humans and Ecosystems: What We Think We Know, and What We Need to Know "

U.S Department of the Interior U.S. Geological Survey

Analysis of Trace Organic Contaminants in Water by Direct Injection Using Agilent 6490 LC/MS/MS with Pos/Neg Switching

6. Using Toxicity Data as Indicators of Water Quality

2012 Nutrient Regulations Update

Wastewater Irrigation on Farms Contaminates Food

Reclaimed Water Current Research and Emerging Contaminants

AN OVERVIEW OF ORGANIC CONTAMINANTS IN THE CHAMPLAIN BASIN

Key challenges in water protection Markus Salomon, Sachverständigenrat für Umweltfragen

Orange County s Groundwater Replenishment System

WHOLE EFFLUENT TOXICITY REDUCTION GUIDANCE

Use of Organic Characterization Techniques to Monitor Advanced Oxidation Processes in Water Reuse And Wastewater Treatment

Effects of Ozone-Treated and Untreated Sediment-Free Oil Sand Processed Water on In Vitro Steroidogenesis

Sampling for EDCs and PPCPs in

The Continued Maturation of Environmental Assessments Over the Last Two Decades: End-of-Pipe to Watershed Strategies

CCME Biosolids Task Group

technical paper Wastewater Disposal

Mark J. Benotti, Ph.D. October 29, Looking Beyond the Parents The Presence and Toxicity of Transformation Products

Dealing with Emerging Contaminants from Air, Land and Sea

High Sensitivity HPLC Analysis of Contaminants of Emerging Concern (CECs) in Water Using the Agilent 6460 Triple Quadrupole LC/MS System

What s in Your Sewage? Dave Humphries, Jeff Charrois, Kristina Stefanizyn Alberta Innovates Technology Futures Vegreville, Alberta

Screening and Examining Exotic Chemicals in Swift. Current Creek, SK, Canada

Contaminants of Emerging Concern in the Delaware River Basin

Today s Webinar: Types of Monitoring and Assessment Data and What They Mean

Fish Health, Pesticides and Endocrine Disruptors

to protect human health and the environment

Pharmaceuticals and Personal Care Products in Drinking Water

BIOMONITORING REQUIREMENTS 48-HOUR ACUTE BIOMONITORING REQUIREMENTS: FRESHWATER

Intersex and other Indicators of Endocrine Disruption throughout the Northeast

COMMENTS BY THE CENTER FOR REGULATORY EFFECTIVENESS ON THE ATRAZINE ENVIRONMENTAL FATE AND EFFECTS RISK ASSESSMENT (DOCKET CONTROL NUMBER OPP-34237C)

Review project investigating pharmaceuticals from a wastewater treatment site.

Wyoming Department of Environmental Quality Water Quality Division WYPDES (Wyoming Pollutant Discharge Elimination System) Program STATEMENT OF BASIS

Drugs Down the Drain: How can we assess and manage the impacts of medicines in the natural environment? Alistair B A Boxall Environment Department

Technical Report on Toxic Contaminants in the Chesapeake Bay and its Watershed: Extent and Severity of Occurrence and Potential Biological Effects

Proceedings of the 14 th International Conference on Environmental Science and Technology Rhodes, Greece, 3-5 September 2015

AND RESEARCH OBJECTIVES

Watershed Chemical Signaling and Endocrine Disruption A Modeling Opportunity

Overview. Emerging Contaminants in Michigan s Water. Emerging Chemical Contaminants. Emerging Chemical Contaminants. Emerging Chemical Contaminants

Toxic Contaminants and Their Effects on Resident Fish and Salmonids

Transcription:

Validation of a Framework for Evaluating the Potential Effects and Risks of Trace Organic Compounds (TOrCs) to Aquatic Life Carrie Turner, John Wolfe and Jen Daley, LimnoTech Allen Burton, University of Michigan Drew McAvoy, University of Cincinnati WEFTEC Water Environment Federation Annual Conference New Orleans, LA Session 417 September 27, 2016

Background Elevated fish intersex observed below WWTP outfalls Due to exposures to endocrine disrupting compounds (EDCs) (e.g. estrogen) Exposures occur simultaneously with many other stressors (e.g. nutrients, metals, pesticides, PAHs, TDS, temperature, altered habitat, flow) A complex puzzle Intersex sturgeon tissue - Diana Papoulias, USGS 3-Year Project for Water Environment & Reuse Foundation (WE&RF) CEC6R12: Testing and Refinement of the Trace Organics Screening Tool Refining and validating a screening tool developed in a 1st Phase of WERF research (2010) for evaluating the effects of trace organics (TOrCs) downstream of utilities. 2

WE&RF s Research on TOrCs Research Areas Treatability Aquatic Ecological Effects Risk Communications Project Summary 50 TOrC-related funded projects Objective Help facility and industry managers make decisions https://www.werf.org/c/knowledgeareas/traceorganics/trace_organics_research_a t_a_glance.aspx 3

WE&RF Project CEC6R12: Testing and Refining Site Screening Tools (Phase 2) Vision for Screening Tools Must be useful and usable by utilities Good fit for existing utility data Easy to interpret results Support sound decisions by utilities Targeted data gathering Effective source control and treatment Promote clearer understanding of complex issues Assist communication with stakeholders & regulators 4

Three Step Framework for Screening Sites for Potential TOrC Risk 1. Determine if biological community is impaired 2. Use existing data to construct lines of evidence for an overall weight-ofevidence assessment of the role of TOrCs in impairment (Level 1 WoE) 3. If warranted, design and conduct a sampling program to generate contemporary datasets for a more detailed weight-of-evidence assessment (Level 2 WoE) 1. Assess biological community 2. Qualitative WoE (Existing Data) 3. Semi-Quantitative WoE (New Data) 5

First Level of Screening: Bio Assessment and Level 1 Weight of Evidence Use existing site data to: Characterize level of impairment Evaluate the roles of TOrCs and other stressors Assign site to a risk level: High, Moderate, Low or Possible Concern So management response can be consistent with risk Accounting for uncertainty Applied to five case study sites with resulting potential risk level of Moderate and Possible Concern 6

Tools to Assist Use of the Site Screening Risk Framework Smaller, cost-effective list of TOrCs to monitor Suggested list of biomarkers to evaluate TOrC effects Risk Calculator model comparing TOrC exposures to TOrC effect levels Level 1 WoE site screening assessment and scoring tool Level 2 WoE scoring examples 7

WERF Indicator TOrCs No Compound CAS # TOrC Class High Priority Treatability Indicator Recommended Indicator TOrCs (use all compounds in assessments and as many as possible in monitoring) Ubiquitous Presence/ Absence Indicator 1 N,N-diethyltoluamide (DEET) 134-62-3 Personal care product Y Y 2 Triclosan 3380-34-5 Personal care product Y Y Y Y 3 Carbamazepine 298-46-4 Pharmaceutical Y Y Y 4 Fluoxetine 54910-89-3 Pharmaceutical Y Y Y 5 Gemfibrozil 25812-30-0 Pharmaceutical Y Y Y 6 Ibuprofen 15687-27-1 Pharmaceutical Y Y Y 7 Meprobamate 57-53-4 Pharmaceutical Y Y Y 8 Sulfamethoxazole 723-46-6 Pharmaceutical Y Y Y 9 Trimethoprim 738-70-5 Pharmaceutical Y Y Y 10 Bisphenol A 80-05-7 Other Y Y Y Y 11 Caffeine 58-08-2 Other Y Y Y 12 Androstenedione 63-05-8 Hormone Y NA Y 13 17β-Estradiol (E2) 50-28-2 Hormone Y NA Y 14 Estrone 53-16-7 Hormone Y Y NA Y Nonpoint Source Indicator TOrCs (select 1-2 compounds for assessment and monitoring) 15 Fluoranthene 1 206-44-0 PAH Y NA Y 16 Atrazine 1912-24-9 Pesticide NA 17 Bifenthrin 1 82657-04-3 Pesticide Y a NA 18 Chlorpyrifos 1 2921-88-2 Pesticide Y NA Y 19 Pentachlorophenol 1 87-86-5 Pesticide Y NA 8

TOrC Risk Calculator Predicts the risk of effluent TOrCs in receiving waters to aquatic life Exposure based on either measured or predicted effluent TOrC concentrations and in-stream dilution Effects based on either laboratory measured or QSAR predicted acute and chronic toxicity Already tabulated in Risk Calculator Risk based on comparing the Predicted Exposure Concentration (PEC) to the Predicted No Effect Concentration (PNEC) using Risk Quotient (RQ) method RQ = [PEC]/[PNEC] RQ > 1 indicates potential risk Benefits Site specific model Easy to use for utility staff Requires only data for a single site Easily updated with new information/data 9

Risk Calculator Example PNEC RQ = PEC / PNEC = 0.081 / 0.02 PEC 10

Case Study Example, Level 1 Weight of Evidence Tier of Concern: Moderate Concern 11

Level One WoE Scoring (Qualitative) Level 1 WoE Element High WoE Factor Score Moderate WoE Factor Score Possible WoE Factor Score Low WoE Factor Score TOrC Effects Multiple surveys show biomarker or other effects Individual survey shows biomarker or other effects Evidence of physical deformities, tumors, and lesions Individual survey shows NO biomarker or other effects TOrC Exposure Risk quotient for more than one indicator compound is greater than 1 using site-specific measured effluent data and 7Q10 flow Risk quotient for one indicator compound is greater than 1 using site-specific measured effluent data and 7Q10 flow Risk quotient for one indicator compound is greater than 1 using literature effluent data and 7Q10 flow Risk quotient for all indicator compounds is less than 1 using measured or literature effluent data and 7Q10 flow TOrC Site Factors Other Stressors Effluent discharge comprises more than 70% of the total stream flow, OR WRRF level of treatment is Primary, OR Treatment effectiveness is poor, based on sludge residence time and effluent concentrations of TSS, BOD and NH3 Habitat is adversely impacted, OR DO exceeds WQS, OR NH3 exceeds WQS, OR at least 3 parameters are identified as potential stressors Effluent discharge comprises between 1% and 70% of the total stream flow, OR WRRF level of treatment is Secondary or Advanced Secondary, OR Treatment effectiveness is moderate, OR At least half of the other risk factors score High At least 2 parameters are identified as potential stressors Incomplete data One parameter is identified as potential stressor Effluent discharge comprises less than 1% of the total stream flow, OR WRRF level of treatment is Tertiary, OR Treatment effectiveness is good, OR At least half of the other risk factors score Moderate or Low No parameters are identified as potential stressors 12

Second Level of Analysis: More Complete Weight of Evidence (Semi- Quantitative) Where screening indicates at least a Moderate Level of Concern: Fill in gaps in site chemistry/community/habitat data Additional biomonitoring, upstream and downstream Characterize relationships between TOrCs, other stressors, and aquatic life impairment Two case study sites where initial screening indicated Moderate or Possible Level of Concern Validate tools and Level 1 WoE results Advance science of TOrC-related biomarker analysis 13

Sampling to Support Multiple Lines of Evidence Chemical loadings (in-stream, WWTP) TOrCs Conventional: nutrients, metals, solids, BOD5, alkalinity, hardness Exposure effects Caged minnows In-situ caged invertebrates In situ toxicity identification evaluation Biological community assessments Stream physical conditions Habitat Dissolved oxygen, temperature, ph, conductivity via sonde Flow (in-stream and at WWTP) 14

TOrC Exposure Levels and Potential Risk Potential Risk Estimated Risk Quotient (RQ) as PEC/PNEC for indicator TOrCs. RQ >1 identified as potential risk Site 1: 1/10 indicator TOrCs have RQ > 1 Site 2: 0/10 indicator TOrCs have RQ > 1 25 compounds analyzed by EPA-Cincinnati Bold compounds = Indicator TOrC TorC Compound Cas No. 4-Nonylphenol 25154-52-3 Androstenedione (ADS) 63-05-8 Atrazine 1912-24-9 Bisphenol A 80-05-7 Caffeine (CFN) 58-08-2 Carbamazepine (CBZ) 298-46-4 Dihydrotestosterone 521-18-6 DNORG (17-Desacetyl Norgestimate) 53016-31-2 DROS (Drospirenone) 67392-87-4 EDA (Ethynodiol Diacetate) 297-76-7 Estradiol (E2) 50-28-2 Estriol 50-27-1 Estrone (E1) 53-16-7 Ethinyl estradiol (EE2) 57-63-6 Levonorgestrel 797-63-7 Medroxyprogesterone Acetate 71-58-9 MEGA (Megestrol Acetate) 3562-63-8 Nonylphenol Diethoxylate 20427-84-3 Nonylphenol Mono Ethoxylate 27986-36-3 Norethindrone 68-22-4 NORG (Norgestimate) 35189-28-7 Progesterone 57-83-0 Testosterone (TST) 58-22-0 Triclocarban 101-20-2 Triclosan (TCC) 3380-34-5 15

Vitellogenin (Vtg) in Liver Samples from Fathead Minnow Males - qpcr Site 1 Site 2 Biales, et al. 2007. Environ. Toxicol. Chem. 26: 287-296 16

Vtg in Plasma Samples from Fathead Minnow Males-ELISA Site 1 Site 2 Statistically significant differences but measured concentrations are close to or below detection limits Statistically significant differences but measured concentrations are close to or below detection limits US Environmental Protection Agency, 2002. EPA/600/R-01/067. Duluth, MN 17

Level 2 Weight-of-Evidence Approach and Semi-Quantative Results Approach Compare downstream to upstream Semi-quantitative scoring using minus signs correlated to: Low effect (0) Possible effect (- -) Moderate effect (-) High effect (- - -) Overall Level of TOrC concern determined Intended as examples that can be adjusted for site-specific conditions Results Level of TOrC Concern 1 Biological Indices TOrC Exposure 18 TOrC Effects Other Stressors Site 1 Low - - - 0 - - - Site 2 Possible - - 0 - - - - Conclusions Impacted stream likely due to non-torc stressors. Continued monitoring suggested Potential wastewater effluent effects. Continued monitoring with special studies suggested

Conclusions Assessment Framework Set of useful tools, within logical risk-based framework Adaptable to site-specific considerations Requires regulatory driver: biological impairment Recognizes potentially confounding role of non-torc stressors WoE consistent with evolving science Tools/protocols are Flexible enough to begin with available data Iterative, for smart data gathering and reduction in key uncertainties Holistic, recognizing potential effects of other stressors on health of aquatic ecosystem Designed to be easy for wastewater utilities to use Final report to be published later this year 19

Questions Carrie Turner Senior Project Engineer LimnoTech (734) 332-1200 cturner@limno.com Lola Olabode Program Director WE&RF (571) 384-2109 lolabode@werf.org 20